HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,461-2,472 of 4,505
Behavioral study icon
CompletedNCT04756388

Examining Strategy Monitoring and Remediation Training

Official study title

E-SMART: Examining Strategy Monitoring and Remediation Training for Schizophrenia

This study has finished and is no longer accepting participants.

In Toronto
SchizophreniaInterventional studyAges 18–65
Countries
Canada
Sponsor
University of Toronto
Other study type icon
CompletedNCT03800368

Exercise and Overnight Motor Sequence Task

Official study title

12-week Aerobic-Anaerobic Transition Exercise Intervention and Overnight Sleep-dependent Procedural Memory Consolidation in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaInterventional studyAges 18–55
Countries
Sponsor
The University of Hong Kong
Drug study icon
CompletedNCT00759421

Exploratory Cognition Study of Sertindole in people with Schizophrenia

Official study title

An Exploratory Cognition Study Conducted as an add-on to Clinical Trial 11286, to Evaluate the Neurocognitive Effects of 12 Weeks Treatment With Sertindole and Olanzapine in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Tapei
SchizophreniaMedication studyAges 18–65
Countries
Taiwan
Sponsor
H. Lundbeck A/S
Behavioral study icon
CompletedNCT07453355

EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA

Official study title

The Role of Expressive Arts Therapy in Strengthening Hope in Individuals With Schizophrenia: A Randomized Controlled Trial (EAT-HOPE)

This study has finished and is no longer accepting participants.

In Atakent
SchizophreniaBehavioural studyAges 18–65
Countries
Türkiye
Sponsor
Ondokuz Mayıs University
Drug study icon
CompletedNCT00139737

Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia

Official study title

Open Extension Study Evaluating the Safety and Tolerability of Oral Ziprasidone in the Treatment of Subjects Who Have Successfully Completed a Previous Ziprasidone Study

This study has finished and is no longer accepting participants.

Multiple locations, including Sora
SchizophreniaMedication studyAges 18–60
Countries
Italy
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.